US Bancorp DE trimmed its position in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 53.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,516 shares of the real estate investment trust's stock after selling 44,446 shares during the quarter. US Bancorp DE's holdings in Medical Properties Trust were worth $152,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MPW. Silver Point Capital L.P. boosted its stake in shares of Medical Properties Trust by 155.3% in the third quarter. Silver Point Capital L.P. now owns 6,000,000 shares of the real estate investment trust's stock worth $35,100,000 after acquiring an additional 3,650,000 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Medical Properties Trust by 353.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,525,714 shares of the real estate investment trust's stock worth $20,625,000 after purchasing an additional 2,748,245 shares during the period. SG Americas Securities LLC grew its holdings in Medical Properties Trust by 435.5% during the 4th quarter. SG Americas Securities LLC now owns 923,756 shares of the real estate investment trust's stock valued at $3,649,000 after buying an additional 751,256 shares in the last quarter. Wilsey Asset Management Inc. raised its position in shares of Medical Properties Trust by 8.5% during the fourth quarter. Wilsey Asset Management Inc. now owns 4,652,803 shares of the real estate investment trust's stock valued at $18,379,000 after buying an additional 362,582 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Medical Properties Trust by 21.7% in the third quarter. JPMorgan Chase & Co. now owns 1,704,785 shares of the real estate investment trust's stock worth $9,973,000 after buying an additional 303,628 shares in the last quarter. Institutional investors own 71.79% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on MPW. BNP Paribas upgraded shares of Medical Properties Trust from a "neutral" rating to an "outperform" rating and lifted their price target for the company from $5.00 to $9.00 in a report on Wednesday, March 12th. Wells Fargo & Company lifted their target price on Medical Properties Trust from $4.00 to $5.00 and gave the stock an "underweight" rating in a report on Monday, March 10th. Truist Financial dropped their price target on Medical Properties Trust from $6.00 to $4.00 and set a "hold" rating for the company in a research note on Thursday, December 19th. Mizuho decreased their price objective on Medical Properties Trust from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Thursday, December 5th. Finally, StockNews.com upgraded Medical Properties Trust from a "sell" rating to a "hold" rating in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $5.64.
Read Our Latest Stock Report on Medical Properties Trust
Insider Buying and Selling at Medical Properties Trust
In other news, CAO James Kevin Hanna sold 11,641 shares of the business's stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $3.72, for a total transaction of $43,304.52. Following the completion of the sale, the chief accounting officer now directly owns 366,913 shares of the company's stock, valued at approximately $1,364,916.36. The trade was a 3.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.53% of the company's stock.
Medical Properties Trust Trading Down 1.0 %
MPW traded down $0.06 during trading on Wednesday, reaching $5.98. The company had a trading volume of 5,151,934 shares, compared to its average volume of 12,836,143. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 1.69. Medical Properties Trust, Inc. has a 52 week low of $3.51 and a 52 week high of $6.55. The stock has a market cap of $3.59 billion, a P/E ratio of -1.42, a PEG ratio of 1.01 and a beta of 1.32. The business has a 50 day simple moving average of $4.92 and a 200-day simple moving average of $4.77.
Medical Properties Trust Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Shareholders of record on Monday, March 10th will be paid a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 5.35%. The ex-dividend date of this dividend is Monday, March 10th. Medical Properties Trust's payout ratio is currently -8.42%.
Medical Properties Trust Profile
(
Free Report)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
See Also

Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.